Citation 10710

RAJIC,A: AKIHISA,T: UKIYA,M: YASUKAWA,K: SANDEMAN,RM: CHANDLER,DS: POLYA,GM:. (2001). INHIBITION OF TRYPSIN AND CHYMOTRYPSIN BY ANTI-INFLAMMATORY TRITERPENOIDS FROM COMPOSITAE FLOWERS.. 67(7)

Citation Details

Title	INHIBITION OF TRYPSIN AND CHYMOTRYPSIN BY ANTI-INFLAMMATORY TRITERPENOIDS FROM COMPOSITAE FLOWERS.
Authors	RAJIC,A: AKIHISA,T: UKIYA,M: YASUKAWA,K: SANDEMAN,RM: CHANDLER,DS: POLYA,GM:
Year	2001
Volume	67
Issue	7

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TARAXASTEROL,PSEUDO:	ACTIVE
2	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TARAXASTEROL,PSEUDO:	ACTIVE
3	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARADIOL	ACTIVE
4	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARADIOL	ACTIVE
5	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARADIOL-3-O-MYRISTATE	ACTIVE
6	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARADIOL-3-O-MYRISTATE	ACTIVE
7	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARADIOL-3-O-PALMITATE	ACTIVE
8	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARADIOL-3-O-PALMITATE	ACTIVE
9	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELIANTRIOL C	ACTIVE
10	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELIANTRIOL C	ACTIVE
11	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELIANTRIOL C 3-O-MYRISTATE	ACTIVE
12	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELIANTRIOL C 3-O-MYRISTATE	ACTIVE
13	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELIANTRIOL C 3-O-PALMITATE	ACTIVE
14	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELIANTRIOL C 3-O-PALMITATE	ACTIVE
15	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TARAXASTEROL	ACTIVE
16	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TARAXASTEROL	ACTIVE
17	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARNIDIOL	ACTIVE
18	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARNIDIOL	ACTIVE
19	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARADIOL ALPHA-EPOXIDE	ACTIVE
20	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FARADIOL ALPHA-EPOXIDE	ACTIVE
21	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANILADIOL	ACTIVE
22	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANILADIOL	ACTIVE
23	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANILADIOL-3-O-MYRISTATE	ACTIVE
24	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANILADIOL-3-O-MYRISTATE	ACTIVE
25	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANILADIOL-3-O-PALMITATE	ACTIVE
26	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANILADIOL-3-O-PALMITATE	ACTIVE
27	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LONGISPINOGENIN	ACTIVE
28	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LONGISPINOGENIN	ACTIVE
29	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELIANTRIOL A-1	ACTIVE
30	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELIANTRIOL A-1	ACTIVE
31	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BREIN	ACTIVE
32	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BREIN	ACTIVE
33	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BREIN-3-O-MYRISTATE	ACTIVE
34	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BREIN-3-O-MYRISTATE	ACTIVE
35	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BREIN-3-O-PALMITATE	ACTIVE
36	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BREIN-3-O-PALMITATE	ACTIVE
37	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALENDULADIOL	ACTIVE
38	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALENDULADIOL	ACTIVE
39	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TARAXEROL	ACTIVE
40	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TARAXEROL	ACTIVE
41	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTENOL	ACTIVE
42	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTENOL	ACTIVE
43	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTENOL,24-METHYLENE:	ACTIVE
44	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTENOL,24-METHYLENE:	ACTIVE
45	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTANETRIOL,24(R):	ACTIVE
46	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTANETRIOL,24(R):	ACTIVE
47	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTANETRIOL,24(S):	ACTIVE
48	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTANETRIOL,24(S):	ACTIVE
49	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTANEDIOL,25-METHOXY: 24(S):	ACTIVE
50	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOARTANEDIOL,25-METHOXY: 24(S):	ACTIVE
51	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARADIENOL	ACTIVE
52	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARADIENOL	ACTIVE
53	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TIRUCALL-7-EN-3-BETA-OL	ACTIVE
54	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TIRUCALL-7-EN-3-BETA-OL	ACTIVE

Citation 10710

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1